COVID-19 Vaccine (inactivated, adjuvanted) Valneva Evrópusambandið - rúmenska - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccinuri - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Foclivia Evrópusambandið - rúmenska - EMA (European Medicines Agency)

foclivia

seqirus s.r.l.  - virusul gripal de suprafață, inactivat: a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccinuri pentru gripă - profilaxia gripei într-o situație pandemică declarată oficial. vaccinul antigripal pandemic trebuie utilizat în conformitate cu orientările oficiale.

Shingrix Evrópusambandið - rúmenska - EMA (European Medicines Agency)

shingrix

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - vaccinuri - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. utilizarea de shingrix ar trebui să fie în conformitate cu recomandările oficiale.

Evant Evrópusambandið - rúmenska - EMA (European Medicines Agency)

evant

laboratorios hipra, s.a. - eimeria acervulina, tulpina 003, eimeria maxima, tulpina 013, eimeria mitis, tulpina 006, eimeria praecox, tulpina 007, eimeria tenella, tulpina 004 - live parazitare vaccinuri, produsele imunologice pentru aves - pui - pentru imunizarea activă a puilor de 1 zi de varsta pentru a reduce leziunile intestinale și oochisturi de ieșire asociate cu coccidioza cauzate de eimeria acervulina, eimeria maxima, eimeria mitis, eimeria praecox și eimeria tenella și pentru a reduce semnele clinice (diaree) asociate cu eimeria acervulina, eimeria maxima și eimeria tenella.

Heplisav B Evrópusambandið - rúmenska - EMA (European Medicines Agency)

heplisav b

dynavax gmbh - hepatita b antigen de suprafață - hepatita b - vaccinuri - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.

Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Evrópusambandið - rúmenska - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - virusul gripei de suprafață (hemaglutinină și neuraminidază) de tulpina a / vietnam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccinuri - imunizarea activă împotriva subtipului h5n1 al virusului gripal a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Arexvy Evrópusambandið - rúmenska - EMA (European Medicines Agency)

arexvy

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - infecții ale virusului sincițial respirator - vaccinuri - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.